BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1708056)

  • 21. Results of signal-averaged electrocardiography and electrophysiologic study in patients with nonsustained ventricular tachycardia after healing of acute myocardial infarction.
    Buxton AE; Simson MB; Falcone RA; Marchlinski FE; Doherty JU; Josephson ME
    Am J Cardiol; 1987 Jul; 60(1):80-5. PubMed ID: 3604948
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antiarrhythmic and electrophysiologic effects of MDL 11,939, a novel class III antiarrhythmic agent in anesthetized dogs.
    Koerner JE; Dage RC
    J Cardiovasc Pharmacol; 1990 Sep; 16(3):383-93. PubMed ID: 1700208
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of DPI 201-106, a novel cardiotonic agent, on hemodynamics, cardiac electrophysiology and arrhythmias induced by programmed ventricular stimulation in dogs with subacute myocardial infarction: a comparative study with dobutamine.
    Ozaki T; Uematsu T; Nagashima S; Nishimoto M; Nakashima M
    Naunyn Schmiedebergs Arch Pharmacol; 1991 Oct; 344(4):478-87. PubMed ID: 1766473
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of prenylamine and AQ-A 39 on reentrant ventricular arrhythmias induced during the late myocardial infarction period in conscious dogs.
    Aidonidis I; Egel E; Hilbel T; Kuebler W; Brachmann J
    J Cardiovasc Pharmacol; 1993 Sep; 22(3):401-7. PubMed ID: 7504130
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of SUN-1165, N-(2,6-dimethylphenyl)-8-pyrrolizidine acetamide hydrochloride hemihydrate, a new class I antiarrhythmic drug, on ventricular arrhythmias, intraventricular conduction, and the refractory period in canine myocardial infarction.
    Hashimoto H; Satoh N; Nakashima M
    J Cardiovasc Pharmacol; 1992 Mar; 19(3):417-24. PubMed ID: 1378123
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarction.
    Lynch JJ; Kitzen JM; Hoff PT; Lucchesi BR
    J Cardiovasc Pharmacol; 1988; 12(5):547-54. PubMed ID: 2468054
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of ajmaline on sustained ventricular tachycardia induced by programmed electrical stimulation in conscious dogs after myocardial infarction.
    Todt H; Krumpl G; Zojer N; Krejcy K; Raberger G
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Sep; 348(3):290-7. PubMed ID: 7694159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiarrhythmic effects of MS-551, a new class III antiarrhythmic agent, on canine models of ventricular arrhythmia.
    Kamiya J; Ishii M; Katakami T
    Jpn J Pharmacol; 1992 Feb; 58(2):107-15. PubMed ID: 1507517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Suppression of ventricular arrhythmias by volatile anesthetics in a canine model of chronic myocardial infarction.
    Deutsch N; Hantler CB; Tait AR; Uprichard A; Schork MA; Knight PR
    Anesthesiology; 1990 Jun; 72(6):1012-21. PubMed ID: 2350016
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of E-4031, a new class III antiarrhythmic drug, on reentrant ventricular arrhythmias: comparison with conventional class I drugs.
    Ogawa S; Mitamura H; Katoh H
    Cardiovasc Drugs Ther; 1993 Aug; 7 Suppl 3():621-6. PubMed ID: 8251432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Rate-dependent anisotropic conduction property in the epicardial border zone of canine myocardial infarcts and its modification by moricizine.
    Tsutsumi N; Mitamura H; Okada Y; Yoshimoto T; Sadanaga T; Furuno I; Ogawa S
    Cardiovasc Drugs Ther; 1995 Oct; 9(5):715-22. PubMed ID: 8573555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of MS-551, a new class III antiarrhythmic drug, on programmed stimulation-induced ventricular arrhythmias, electrophysiology, and hemodynamics in a canine myocardial infarction model.
    Kondoh K; Hashimoto H; Nishiyama H; Umemura K; Ozaki T; Uematsu T; Nakashima M
    J Cardiovasc Pharmacol; 1994 Apr; 23(4):674-80. PubMed ID: 7516022
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapy for late post infarction ventricular tachycardia.
    Somberg JC; Butler B; Torres V; Tepper D; Keren G; Siegel L; Jentzer J; Miura DS
    Angiology; 1985 Mar; 36(3):181-90. PubMed ID: 3896040
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Proarrhythmic effects of procainamide and tocainide in a canine infarction model.
    Steinberg JS; Sahar DI; Rosenbaum M; Cook JR; Bigger JT
    J Cardiovasc Pharmacol; 1992 Jan; 19(1):52-9. PubMed ID: 1375688
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pirmenol hydrochloride (CI-845) and reference antiarrhythmic agents: effects on early ventricular arrhythmias after acute coronary artery ligation in anesthetized rats.
    Mertz TE; Kaplan HR
    J Pharmacol Exp Ther; 1982 Nov; 223(2):580-6. PubMed ID: 7131307
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Halothane anesthesia reduces inducibility of ventricular tachyarrhythmias in chronic canine myocardial infarction.
    Denniss AR; Richards DA; Taylor AT; Uther JB
    Basic Res Cardiol; 1989; 84(1):5-12. PubMed ID: 2923606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of effects of three anesthetic agents on induction of ventricular tachycardia in a canine model of myocardial infarction.
    Hunt GB; Ross DL
    Circulation; 1988 Jul; 78(1):221-6. PubMed ID: 3383405
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spontaneous ventricular tachycardia associated with isolated right ventricular infarction, one day after right coronary artery occlusion in the dog: studies on the site of origin and mechanism.
    Sugi K; Karagueuzian HS; Fishbein MC; McCullen A; Sato Y; Ganz W; Mandel WJ; Peter T
    Am Heart J; 1985 Feb; 109(2):232-44. PubMed ID: 3966341
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Electropharmacology of the bradycardic agents alinidine and zatebradine (UL-FS 49) in a conscious canine ventricular arrhythmia model of permanent coronary artery occlusion.
    Aidonidis I; Brachmann J; Rizos I; Zacharoulis A; Stavridis I; Toutouzas P; Kübler W
    Cardiovasc Drugs Ther; 1995 Aug; 9(4):555-63. PubMed ID: 8547205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antiarrhythmic and electrophysiologic effects of bepridil in chronically infarcted conscious dogs.
    Lynch JJ; Montgomery DG; Ventura A; Lucchesi BR
    J Pharmacol Exp Ther; 1985 Jul; 234(1):72-80. PubMed ID: 3874285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.